Eunhee S. Yi

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 5 papers. Top paper: “Preclinical and Toxicology Studies of BRD5529, a Selective Inhibitor of CARD9”.

Preclinical and Toxicology Studies of BRD5529, a Selective Inhibitor of CARD9

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.11.19.469250

N/A

0DataRank · unranked

1 citations

Kyle Schaefbauer, Eva M. Carmona, Eunhee S. Yi, Andrew H. Limper, Theodore J. Kottom

Targeting Pulmonary Fibrosis by SLC1A5-Dependent Glutamine Transport Blockade

American Journal of Respiratory Cell and Molecular Biology(2023)10.1165/rcmb.2022-0339oc

N/A

0DataRank · unranked

27 citations

Kyle Schaefbauer, Theodore J. Kottom, Eunhee S. Yi, Daniel J. Tschumperlin, Andrew H. Limper +1 more

Preclinical and Toxicology Assessment of ALW-II-41-27, an Inhibitor of the Eph Receptor A2 (EphA2)

Drugs in R&D(2024)10.1007/s40268-024-00483-5

N/A

0DataRank · unranked

3 citations

Kimberly E. Stelzig, Madeline R. Pellegrino, Marc Bindzus, Eunhee S. Yi, Andrew H. Limper +1 more

Lung adenocarcinoma patients with ROS1-rearranged tumors by sex and smoking intensity

Heliyon(2024)10.1016/j.heliyon.2024.e28285

N/A

0DataRank · unranked

0 citations

Vinicius Ernani, Dan Liu, Qian Guo, Markay Hopps, Joseph C. Cappelleri +6 more

Spatially defined intratumoral immune biomarkers predict recurrent versus second primary tumors in non-small cell lung cancer

Precision Clinical Medicine(2025)10.1093/pcmedi/pbaf001

N/A

0DataRank · unranked

1 citations

Alanna Maguire, Eunhee S. Yi, Yanmei Peng, Jennifer M. Kachergus, András Khoór +14 more